A microfluidic model of bacterial keratitis to quantify the efficacy of anti-infective compounds under flow

Clicks: 3
ID: 338881
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #222 of 222 articles by views in Journal of applied microbiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 222 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
AIMS: Bacterial infections of the cornea, also known as bacterial keratitis, are a major cause of blindness. The corneal surface is protected against infection by the flow of tear fluid, which displaces potential pathogens and debris. Whilst fluid flow is known to influence the behaviour of both bacterial and epithelial cells, most models of corneal infection use static conditions. Here, we develop a microfluidic model to directly visualise interactions between bacteria and human corneal epithelial cells (HCE2) in physiologically relevant flow conditions. METHODS AND RESULTS: We use high-resolution microscopy and automated image analysis to continuously quantify the rate at which Staphylococcus aureus (SH1000) and Pseudomonas aeruginosa (PAO1) adhere to HCE2 monolayers. We then use this system to investigate the effects of pre-treatment with unfractionated heparin (UFH), a putative therapeutic compound thought to inhibit bacterial adhesion. Using a traditional, well plate-based assay that lacks fluid flow, prior treatment of HCE2 monolayers with UFH significantly reduced adhesion of both species. In our microfluidic model we found that pre-treating HCE2 monolayers with UFH again sharply reduced S. aureus adhesion, but surprisingly, UFH pre-treatment had no effect on P. aeruginosa adhesion to corneal cells in the presence of fluid flow. CONCLUSIONS: Our findings demonstrate that incorporating fluid flow into in vitro infection models can lead to qualitatively different outcomes when screening putative anti-adhesion therapies. These findings, obtained using two widely studied model strains, illustrate how microfluidic models of infection can offer valuable insights into how flow influences bacterial keratitis and guide the development of new treatments.
Reference Key
openalex_W7225334143 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lucy Urwin, James H. R. Wheeler, Paige A. Wolverson, Luke R. Green, Mahendra P. Raut, Esther Karunakaran, Lynda J. Partridge, Peter N. Monk, William M. Durham
Are you one of these authors? Claim your profile
Journal Journal of applied microbiology
Year 2026
DOI
10.1093/jambio/lxag263
URL
https://doi.org/10.1093/jambio/lxag263
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.